APA (7th ed.) Citation

Kim, H., Kim, H., Feng, Y., Li, Y., Tamiya, H., Tocci, S., & Ronai, Z. A. (2020). PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Science translational medicine, 12(551), . https://doi.org/10.1126/scitranslmed.aaz5683

Chicago Style (17th ed.) Citation

Kim, Hyungsoo, Heejung Kim, Yongmei Feng, Yan Li, Hironari Tamiya, Stefania Tocci, and Ze'ev A. Ronai. "PRMT5 Control of CGAS/STING and NLRC5 Pathways Defines Melanoma Response to Antitumor Immunity." Science Translational Medicine 12, no. 551 (2020). https://doi.org/10.1126/scitranslmed.aaz5683.

MLA (9th ed.) Citation

Kim, Hyungsoo, et al. "PRMT5 Control of CGAS/STING and NLRC5 Pathways Defines Melanoma Response to Antitumor Immunity." Science Translational Medicine, vol. 12, no. 551, 2020, https://doi.org/10.1126/scitranslmed.aaz5683.